What are the Core Details of the Kuva Labs Acquisition of Lisata Therapeutics

Related Articles

What are the Core Allegations Against Helen of Troy

4 months ago

What is the Core of the Ring Facial Recognition Lawsuit

4 months ago

Is Planet Labs (PL) a Beneficiary of the "Great Rotation" into the Real Economy

6 months ago

What Does Cintas's Acquisition of UniFirst Mean for the Industry

6 months ago

Category

You may also like

Stock News•1 months ago

Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings

Skye Bioscience and Redx Pharma agreed to combine, creating Nasdaq-listed Fibrx Therapeutics, a fibrosis-focused company led by Redx management. Concurrent financings of ~$125 million will fund operat...

SKYE

Share

Stock News•2 months ago

Lisata Therapeutics Provides Update Following Termination of Merger Agreement

Lisata Therapeutics filed suit against Kuva Labs and its subsidiary seeking damages for stockholders, after Kuva terminated their merger agreement. The legal action could affect deal-related recoverie...

LSTA

Share

Stock News•2 months ago

Lantheus Holdings to Be Acquired for Initial $6.7 Billion

Lantheus Holdings will be acquired by Curium for $6.7 billion, or $102.50 per share in cash, a 2.9% premium to Friday's close and 8.5% above May 21 levels, after Bloomberg reported Curium's interest.

LNTH

Share